MedPath

Treatment of Cerebro-asthenia by Unani medicine HabbeJadwar Kochak

Phase 3
Conditions
Health Condition 1: F488- Other specified nonpsychotic mental disorders
Registration Number
CTRI/2020/07/026544
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

The patients fulfilling the following criteria will be included in this study:

1. Patients of either sex in the age group 40-65 years.

2. Patients of á¸?uâ??f al-DimÄ?gh (Cerebro-asthenia) having subjective complaints of

cognitive impairment:

a. Memory loss

b. Mild headache

c. Anxiety

d. ButlÄ?n-i-Takallum (Speech impairment)

e. ButlÄ?n-i-TahrÄ«r (Writing impairment)

3. MMSE score of 10-23 representing mild to moderate cognitive impairment

Exclusion Criteria

The patients having any of the following criteria will be excluded from the study:

1. Clinical presentation and/or history of any significant organic neurological diseases

including space occupying lesions, stroke, head injury, seizure, and mental

retardation.

2. Secondary causes of dementia including hypothyroidism or hyperthyroidism.

3. Known cases of B12 vitamin deficiencies.

4. Clinical presentation and known case of a chronic disease that requires long-term

treatment.

5. Patients on Psychotropic Drugs

6. H/o alcohol or substance abuse or dependence.

7. H/o Hypersensitivity to the study drug or any of its ingredients

8. Pregnant and lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath